Most readers would already be aware that Novanta's (NASDAQ:NOVT) stock increased significantly by 42% over the ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain ...

Novanta delivers advanced photonics and precision motion components for medical and industrial OEMs worldwide.

CEO Matthijs Glastra stated that "Novanta delivered solid second quarter results, meeting or exceeding expectations for sales, margins and profit. Revenue reached $241 million, which represents ...

According to an SEC filing dated February 13, 2026, ACK Asset Management LLC bought 375,000 shares of Novanta, marking a new position. The quarter-end value of the position totaled $44.62 million.

The following provides additional explanations for non-GAAP financial measures used by the Company, including explanations for certain non-GAAP adjustments that may not be present in the quarterly ...

Novanta Inc. is a leading tech provider facing macroeconomic headwinds and a soft demand climate, which have pressured its revenue and profitability. Despite strong fundamentals and a solid market ...

Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that its Board of Directors has authorized the ...

Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary ...

Identiv and Novanta to market new RFID-based solutions that fill much needed gap for medical device and pharmaceutical manufacturers The initial focus of this collaboration will be to market RFID ...

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results ...